CLEVELAND, Ohio, June 2 /PRNewswire/ -- Simbionix has announced the release of a new and exciting module for its LAP Mentor simulator that gives trainees hands-on experience with different techniques and alternative approaches to the treatment of ectopic pregnancy, tubal sterilization and oophorectomy.
The GYN module is the latest addition to the suite of laparoscopic procedures developed for the LAP Mentor, the world's most advanced laparoscopic surgery simulator. The GYN module makes full use of the LAP Mentor's 3-D real-life graphics and ergonomically designed hardware to provide the most realistic experience of training and learning possible.
The module includes an expandable library of virtual patients with a variety of anatomical anomalies and complications, a complete set of laparoscopic instruments including those unique to GYN procedures, exceptional audio and visual learning aids and a comprehensive set of performance metrics.
In announcing the release of the new module, Simbionix President Ran Bronstein commented: "This demonstrates Simbionix continued commitment to our LAP customers. We are committed to continuous on going development that will keep the LAP Mentor the most advanced laparoscopic system on the market. Our goal is to assure customers unsurpassed value and maximum benefits from their purchase of Simbionix Simulators".
About Simbionix USA Corporation
Simbionix is the industry leader in the development of innovative and
effective medical simulation products used for clinical education and
training of medical professionals. Simbionix products are designed to
accelerate best-practice medical training, advance clinical performance and
improve patient safety. The company is committed to continuously innovating
and broadening its product offerings with a wide range of training modules,
case studies and scenarios, developed in response to the growing importance
of clinical training and education as a means of achieving improved patient
Additional company information can be found at http://www.simbionix.com
Copyright©2008 PR Newswire.
All rights reserved